New chemo cocktail aims to boost stomach cancer cure rates
NCT ID NCT03773367
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 30 times
Summary
This study tests whether adding a third chemotherapy drug (irinotecan) to the standard two-drug regimen before and after surgery can improve outcomes for people with resectable stomach or gastroesophageal junction cancer. About 60 adults with early-stage, operable cancer will receive 4 cycles of the three-drug combo before surgery and 4 cycles after. The goal is to see if this stronger approach leads to better tumor shrinkage and higher cure rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESECTABLE GASTRIC AND GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Centrallasarettet i Växjö
Vaxjo, 352 34, Sweden
-
Karolinska University Hospital
Stockholm, 141 86, Sweden
-
Lund University Hospital
Lund, 221 85, Sweden
-
Oslo University Hospital, Ullevål Hospital
Oslo, 0450, Norway
Conditions
Explore the condition pages connected to this study.